Myeloid Malignancy Flashcards
Myeloid Malignancy
Acute Myeloid Leukaemia (AML)
Chronic Myeloid Leukaemia (CML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Diseases (MPD)
All arise from mutational events (acquired) in the stem cell compartment. Different mutations lead to different phenotypes of disease.
Clinical features of AML
Bone marrow failure
- anaemia
- thrombocytopenic bleeding (purpura and mucosal membrane bleeding)
- infection because of neutropenia which is predominantly bacteria and fungal
Investigations in AML
Blood count and blood film
Bone marrow aspirate/ trephine biopsy
Cytogenetics of leukaemic blasts (karyotyping)
Immunophenotyping of leukaemic blasts
CSF examination if symptoms
Molecular genetics for associated acquired gene mutations (FLT3, NPM1, IDH1 and 2)
Treatment of AML
Supportive Care
Anti-leukaemic Chemotherapy (Intensive chemotherapy, produces complete and absolute neutropenia for 2/3 weeks)
Stem Cell Transplantation
- Allogeneic
All-trans Retinoic Acid and Arsenic Trioxide which leads to differentiation of leukaemic blasts
Mylotarg
Midostaurin
Science of CML
translocation 9-22 (phildelphia chromosome) at the stem cell area. This leads to proliferation and differentiation. Marked accumulation of Neutrophils, Eosinophils, Basophils, Monocytes etc.
Presentation of CML
Anaemia Splenomegaly Weight loss due to hypercatabolic Hyperleukostasis - fundal haemorrhage and venous congestion resulting in altered consciousness and respiratory failure Gout
Lab features of CML
High WCC ( can be very high )
High platelet count
Anaemia
Blood film shows all stages of white cell differentiation with increased basophils
Bone marrow is hypercellular
Bone marrow and blood cells contain the Philadelphia chromosome - t(9;22)
Treatment of CML
Imatinib (Glivec) Dasatinib (Sprycel) Nilotinib (Tasigna) Busitinib Ponatinib
These are all tyrosine kinase inhibitors (direct inhibitors of BCR-ABL)
Allogeneic Transplantation in TKI failure
Myelodysplastic Syndromes
Pre-leukaemic acquired clonal disorders of the bone marrow whoch are commonly seen in old age
Presentation of myelodysplastic syndromes
Macrocytic anaemia and pancytopenia (bone marrow failure)
Why are myelodysplastic syndromes fatal
Progression to bone marrow failure or AML
Treatment of myelodysplastic syndromes
Supportive or allogeneic stem cell transplantation for the few young patients.
Myeloproliferative Diseases
Polycythaemia Vera (overproduction of red cells)
Essential Thrombocythaemia (overproduction of platelets)
Idiopathic Myelofibrosis (proliferation of megalokaryocytes which leads to accumulation of chemicals which result in fibrosis of bone marrow)
Findings of Polycythaemic Vera
Increased haematocrit (70%), increased in red cell, white cell and megalocaryocytes. Slight bone marrow fibrosis.
Genetic abnormality in Myeloproliferative Neoplasms
JAK2 gene V617F Mutation
In the mutation, the proliferative pathways are switched on all the time, they are independent of regulator (erythropoetin)
Most commonly occurs in polycythaemia vera